These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23992250)

  • 21. Reply to 'Differential response to bypassing agents complicates treatment in patients with haemophilia and inhibitors' (Haemophilia 2009; 15: 3-10).
    Hedner U
    Haemophilia; 2010 Mar; 16(2):372-3. PubMed ID: 20028420
    [No Abstract]   [Full Text] [Related]  

  • 22. Diagnosis and treatment of acquired haemophilia.
    Baudo F; Caimi T; de Cataldo F
    Haemophilia; 2010 May; 16(102):102-6. PubMed ID: 20536992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Phase II clinical trial of a mixture of plasma-derived factor VIIa and factor X (MC710) in haemophilia patients with inhibitors: haemostatic efficacy, safety and pharmacokinetics/pharmacodynamics.
    Shirahata A; Fukutake K; Takamatsu J; Shima M; Hanabusa H; Mugishima H; Amano K; Takedani H; Tamashima S; Matsushita T; Tawa A; Tanaka I; Higasa S; Kosaka Y; Fujii T; Sakai M; Migita M; Kawakami K; Ohashi Y; Saito H
    Haemophilia; 2013 Nov; 19(6):853-60. PubMed ID: 23738888
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term secondary prophylaxis with recombinant activated factor VII (rFVIIa) in haemophilia A with inhibitors: a case report.
    Kubisz P; Plamenová I; Stasko J; Dobrotová M; Hollý P
    Thromb Haemost; 2010 Apr; 103(4):868-70. PubMed ID: 20135075
    [No Abstract]   [Full Text] [Related]  

  • 25. Control of variceal bleeding in a patient with severe haemophilia A and factor VIII inhibitors using a transjugular intrahepatic portosystemic shunt.
    Hurst E; Talks K; Hanley J
    Haemophilia; 2010 Jul; 16(4):708-9. PubMed ID: 20398076
    [No Abstract]   [Full Text] [Related]  

  • 26. [Bullous pemphigoid and acquired haemophilia].
    Kluger N; Navarro R; Pallure V; Guillot B
    Ann Dermatol Venereol; 2011 May; 138(5):422-3. PubMed ID: 21570569
    [No Abstract]   [Full Text] [Related]  

  • 27. When should prophylaxis therapy in inhibitor patients be considered?
    Young G; Auerswald G; Jimenez-Yuste V; Konkle BA; Lambert T; Morfini M; Santagostino E; Blanchette V
    Haemophilia; 2011 Sep; 17(5):e849-57. PubMed ID: 21418444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is a reduced intensity treatment with Rituximab effective in acquired haemophilia A?
    Castaman G; Tosetto A
    Haemophilia; 2011 Sep; 17(5):817-8. PubMed ID: 21371198
    [No Abstract]   [Full Text] [Related]  

  • 29. Management of difficult-to-treat inhibitor patients.
    Giangrande PL; Escobar MA
    Haemophilia; 2010 May; 16 Suppl 3():52-7. PubMed ID: 20586803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extensive bleeding due to an inhibitor in a haemophilia A patient with a Tyr2105Cys mutation: elimination of the inhibitor with rituximab.
    Williams VK; Pham C; Suppiah R
    Pathology; 2015 Oct; 47(6):586-8. PubMed ID: 26308136
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical and echographical control protocol of haemarthrosis in haemophilia patients with inhibitors: evaluation of the efficacy of recombinant factor VIIa in the evolution process (EFFISEVEN protocol).
    Querol F; Cortina V; Cid AR; Haya S; Aznar JA
    Haemophilia; 2008 Nov; 14 Suppl 6():36-44. PubMed ID: 19134032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A case of acquired haemophilia A complicated by peritonitis after distal gastrectomy.
    Sato K; Tsukada N; Inamura J; Kon M; Ito S; Hirai K; Hosoki T
    Haemophilia; 2016 Sep; 22(5):e469-71. PubMed ID: 27457489
    [No Abstract]   [Full Text] [Related]  

  • 33. Acquired Hemophilia A Presenting as Intramuscular Hematoma.
    Al-Shbool G; Vakiti A
    J Investig Med High Impact Case Rep; 2018; 6():2324709618817572. PubMed ID: 30574513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liver transplantation in a patient with mild haemophilia A and low-titres of factor VIII inhibitors treated with recombinant factor VIIa. The first Argentinean case.
    Guglielmone H; Jarchum G; Minoldo S
    Haemophilia; 2011 Mar; 17(2):317-8. PubMed ID: 21332883
    [No Abstract]   [Full Text] [Related]  

  • 35. A case of acute upper and lower airway obstruction due to retropharyngeal haemorrhage secondary to acquired haemophilia A.
    Harper M; Obolensky L; Roberts P; Mercer M
    Anaesthesia; 2007 Jun; 62(6):627-30. PubMed ID: 17506746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acquired Hemophilia A in Wiskott-Aldrich Syndrome.
    He T; Cao K; Qi Z; Xia Y; Ling J; Wang L; Huang Y; Yang J
    J Clin Immunol; 2021 Jul; 41(5):1119-1122. PubMed ID: 33660143
    [No Abstract]   [Full Text] [Related]  

  • 37. Excision of pseudotumour in a patient with haemophilia A and inhibitor managed with recombinant factor VIIa.
    Takedani H; Mikami S; Kawasaki N; Abe Y; Arai M; Naka H; Yoshioka A
    Haemophilia; 2004 Mar; 10(2):179-82. PubMed ID: 14962208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A child with acquired haemophilia.
    Somaratne PD; Jansan J; Senanayake HM; Ratnamalala V; Jayathilake MM; Thirumavalavan K
    Ceylon Med J; 2014 Jun; 59(2):66-7. PubMed ID: 24977427
    [No Abstract]   [Full Text] [Related]  

  • 39. Successful total hip replacement with sequential administration of bypassing agents in an adolescent boy with hemophilia A and high inhibitor titers.
    Kaya Z; Orhan Ö; Turanlı S; Yenicesu İ; Koçak Ü; Gürsel T
    Blood Coagul Fibrinolysis; 2017 Jul; 28(5):419-422. PubMed ID: 28079537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New advances in the therapeutic and laboratory management of patients with haemophilia and inhibitors.
    Dargaud Y; Lambert T; Trossaert M
    Haemophilia; 2008 Jul; 14 Suppl 4():20-7. PubMed ID: 18494689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.